| CNIO News - CNIO

Home | News | CNIO News


Scientific News
A major European project involving CNIO seeks to detect pancreatic cancer in its early stages through a blood test Pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic cancer, is usually...
Outreach to Society
CNIO science at the ‘Madrid es Ciencia’ outreach fair “We do research to prevent, diagnose and treat cancer” is the slogan of the CNIO...
23.03.2023 Gonzalo Aizpurua, Anabel Sáez and Joseph Thomson, awarded with “la Caixa” Foundation fellowships Gonzalo Aizpurua de Arteche, Anabel Sáez Mas and Joseph Thomson, young researchers at the Spanish... 21.03.2023 Tak W. Mak, immunologist: “I am not doing science for recognition” Tak W. Mak (Hong Kong, 1946) is the author of some of the major findings of recent decades on the... Scientific News
Scientists identify the mechanisms leading to resistance to lung cancer treatment with Sotorasib, the first KRAS inhibitor According to recent figures published by the Spanish Society of Medical Oncology (SEOM), more than...
16.03.2023 Mariano Barbacid receives the National Research Award: “We discovered the first oncogenes, now more than 500 are known” Mariano Barbacid, head of the Experimental Oncology Group at the CNIO, has been recognized with the... Scientific News
CNIO researchers collect samples from cabin crew members to investigate the relationship between cancer and jet lag Our body’s circadian rhythm is “the biological clock that allows us to adapt to an...
CNIO researchers propose biomarkers to select breast cancer patients who could benefit from denosumab treatment The drug denosumab is currently used to treat osteoporosis and bone metastases. For more than a...
Scientific News
The largest genomic study of rare cancer metastatic pheochromocytoma identifies patients at highest risk of metastasis and those who would respond to immunotherapy Pheochromocytoma is a rare tumor, with an incidence of three to eight cases per million population...